Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis. <i>J. Clin. Med.</i> 2022, <i>11</i>, 3239”
This is an Author Reply to the Letter to the Editor entitled “Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis” by Daitch V. et al. [...]
Main Authors: | Chienhsiu Huang, Ihung Chen, Tiju Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/24/7508 |
Similar Items
-
Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-06-01) -
Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis. <i>J. Clin. Med</i>. 2022, <i>11</i>, 3239
by: Vered Daitch, et al.
Published: (2022-11-01) -
Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01) -
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)